Try our Advanced Search for more refined results
Bristol-Myers Squibb Co.
-
Utility | Filed: May 31, 2024 | Entered: May 31, 2024 Pfizer Inc. et al v. Changzhou Pharmaceutical Factory
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Add Attorneys - PHV only
Pro Hac Vice Attorney Dimitrios T. Drivas for Pfizer Inc.,and for Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam)
-
Utility | Filed: May 31, 2024 | Entered: May 31, 2024 Pfizer Inc. et al v. Changzhou Pharmaceutical Factory
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Add Attorneys - PHV only
Pro Hac Vice Attorney John P. Scheibeler for Pfizer Inc. and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam)
-
Utility | Filed: May 31, 2024 | Entered: May 31, 2024 Pfizer Inc. et al v. Changzhou Pharmaceutical Factory
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Add Attorneys - PHV only
Pro Hac Vice Attorney Joel L. Broussard for Pfizer Inc. and for Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login